New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.
- DOI
- 10.1016/s1470-2045(24)00736-8
- Published
- 2025 Apr
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-24-00736-8,
title = {New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.},
author = {Pearson ADJ and Rossig C and Mackall CL and Shah NN and Baruchel A and Daems S and Anderson J and Biondi A and Bird N and Bodmer N and Brivio E and Buechner J and Calkoen FG and Cooper T and de Rojas T and Fox E and Gardner R and Ghorashian S and Heenen D and Ifversen M and Jacoby E and Juan M and Knox L and Komanduri K and Larghero J and Locatelli F and Ludwinski D and Majzner RG and McDonough J and Minard-Colin V and Nysom K and Pappo A and Park JR and Qasim W and Quintarelli C and Rives S and Rouce RH and Scobie N and Seitz C and Tasian SK and Weigel B and Weiner S and Zwaan CM and Vassal G},
year = {2025},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(24)00736-8},
url = {https://doi.org/10.1016/s1470-2045(24)00736-8}
}RIS
TY - JOUR TI - New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis. AU - Pearson ADJ AU - Rossig C AU - Mackall CL AU - Shah NN AU - Baruchel A AU - Daems S AU - Anderson J AU - Biondi A AU - Bird N AU - Bodmer N AU - Brivio E AU - Buechner J AU - Calkoen FG AU - Cooper T AU - de Rojas T AU - Fox E AU - Gardner R AU - Ghorashian S AU - Heenen D AU - Ifversen M AU - Jacoby E AU - Juan M AU - Knox L AU - Komanduri K AU - Larghero J AU - Locatelli F AU - Ludwinski D AU - Majzner RG AU - McDonough J AU - Minard-Colin V AU - Nysom K AU - Pappo A AU - Park JR AU - Qasim W AU - Quintarelli C AU - Rives S AU - Rouce RH AU - Scobie N AU - Seitz C AU - Tasian SK AU - Weigel B AU - Weiner S AU - Zwaan CM AU - Vassal G PY - 2025 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(24)00736-8 UR - https://doi.org/10.1016/s1470-2045(24)00736-8 ER -
APA
ADJ, P., C, R., CL, M., NN, S., A, B., S, D., J, A., A, B., N, B., N, B., E, B., J, B., FG, C., T, C., T, D. R., E, F., R, G., S, G., D, H., M, I., E, J., M, J., L, K., K, K., J, L., F, L., D, L., RG, M., J, M., V, M., K, N., A, P., JR, P., W, Q., C, Q., S, R., RH, R., N, S., C, S., SK, T., B, W., S, W., CM, Z., & G, V. (2025). New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(24)00736-8
Source records
- pubmed · retrieved 2026-09-26T03:05:11.364Z